ZERIPATAMIG

UNII:	BK3WC9ZP7A
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ZERIPATAMIG
GSRS Full Record:	BK3WC9ZP7A i

2607644-43-7
ANTI-CD47/CD19 BISPECIFIC MONOCLONAL ANTIBODY TG-1801
Immunoglobulin G1 [de-446-lysine], bispecific, anti-(human CD19 antigen) (human monoclonal TG-1801 γ1-chain) disulfide with human monoclonal TG-1801 λ-chain, bis(disulfide) with immunoglobulin G1 anti-(human CD47 antigen) (human monoclonal TG-1801 γ1-chain) disulfide with human monoclonal TG-1801 κ-chain
TG 1801 [WHO-DD]
TG-1801
TG1801
Zeripatamig
immunoglobulin G1-kappa/lambda, anti-[Homo sapiens CD47 (integrin-associated protein, IAP, MER6, OA3) and anti-[Homo sapiens CD19 (B lymphocyte surface antigen B4, Leu-12)], Homo sapiens monoclonal antibody, bispecific
zeripatamig [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZERIPATAMIG

Synonyms and Mappings

Resources